美股A股
StockGist
Back
8-K2026-03-19· x-ai/grok-4.1-fast

INKT · MiNK Therapeutics, Inc.

0001193125-26-116219

SEC filing

Summary

MiNK Therapeutics Inc. appointed Melissa Orilall as Principal Financial Officer and Austin Charette as Principal Accounting Officer, effective March 13, 2026. Both officers provide services through an Amended and Restated Intercompany Services Agreement with Agenus Inc., with no new compensation arrangements or family relationships disclosed.

Key takeaways